Author: Diagnostic Vision

Cancer research is entering an era defined not by incremental improvements in existing drugs but by entirely new ways of attacking tumours, technologies that marry biology with engineering and physics. Two of the most intriguing developments, emerging independently from China and the United States, are capturing global attention and could shape the next generation of UK clinical trials and treatments. Stem cell-derived natural killer (NK) cells capable of producing millions of tumour-killing warriors, and ultrasound-activated nanobubbles designed to breach tough tumour barriers. These innovations underscore a broader shift in oncology over the past decade. Away from one-size-fits-all cytotoxic chemotherapy and…

Read More